Achsah D. Keegan - Publications

Affiliations: 
Molecular Microbiology and Immunology University of Maryland School of Medicine, Baltimore, MD, United States 
Area:
Immunology, Molecular Biology

89 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2024 Chapoval SP, Gao H, Fanaroff R, Keegan AD. Plexin B1 controls Treg numbers, limits allergic airway inflammation, and regulates mucins. Frontiers in Immunology. 14: 1297354. PMID 38259471 DOI: 10.3389/fimmu.2023.1297354  0.404
2022 Gopalakrishnan A, Joseph J, Shirey KA, Keegan AD, Boukhvalova MS, Vogel SN, Blanco JCG. Protection against influenza-induced Acute Lung Injury (ALI) by enhanced induction of M2a macrophages: possible role of PPARγ/RXR ligands in IL-4-induced M2a macrophage differentiation. Frontiers in Immunology. 13: 968336. PMID 36052067 DOI: 10.3389/fimmu.2022.968336  0.392
2021 Keegan AD, Leonard WJ, Zhu J. Recent advances in understanding the role of IL-4 signaling. Faculty Reviews. 10: 71. PMID 34557875 DOI: 10.12703/r/10-71  0.414
2019 Chapoval SP, Hritzo M, Qi X, Tamagnone L, Golding A, Keegan AD. Semaphorin 4A Stabilizes Human Regulatory T Cell Phenotype via Plexin B1. Immunohorizons. 3: 71-87. PMID 31236543 DOI: 10.4049/immunohorizons.1800026  0.343
2018 Clark SM, Song C, Li X, Keegan AD, Tonelli LH. CD8 T cells promote cytokine responses to stress. Cytokine. PMID 30033139 DOI: 10.1016/J.Cyto.2018.07.015  0.414
2018 Keegan AD, Zamorano J, Keselman A, Heller NM. IL-4 and IL-13 Receptor Signaling From 4PS to Insulin Receptor Substrate 2: There and Back Again, a Historical View. Frontiers in Immunology. 9: 1037. PMID 29868002 DOI: 10.3389/Fimmu.2018.01037  0.466
2016 Weingartner E, Courneya JP, Keegan A, Golding A. A novel method for assaying human regulatory T cell direct suppression of B cell effector function. Journal of Immunological Methods. 441: 1-7. PMID 27851889 DOI: 10.1016/J.Jim.2016.11.004  0.353
2016 Dasgupta P, Dorsey NJ, Li J, Qi X, Smith EP, Yamaji-Kegan K, Keegan AD. The adaptor protein insulin receptor substrate 2 inhibits alternative macrophage activation and allergic lung inflammation. Science Signaling. 9: ra63. PMID 27330190 DOI: 10.1126/Scisignal.Aad6724  0.777
2016 Song C, Nicholson JD, Clark SM, Li X, Keegan AD, Tonelli LH. Expansion of Brain T cells in Homeostatic Conditions in Lymphopenic Rag2(-/-) Mice. Brain, Behavior, and Immunity. PMID 27013354 DOI: 10.1016/J.Bbi.2016.03.017  0.351
2015 Zhang ZQ, Wang J, Hoy Z, Keegan A, Gigliotti F, Wright T. Neither classical nor alternative macrophage activation is required for Pneumocystis clearance during immune reconstitution inflammatory syndrome. Infection and Immunity. PMID 26371121 DOI: 10.1128/Iai.00763-15  0.473
2015 Keegan AD. IL-4 and IL-13: from "supe" to nuts. Cytokine. 75: 1-2. PMID 26168691 DOI: 10.1016/J.Cyto.2015.06.001  0.453
2015 Palaniyandi S, Liu X, Periasamy S, Ma A, Tang J, Jenkins M, Tuo W, Song W, Keegan AD, Conrad DH, Zhu X. Inhibition of CD23-mediated IgE transcytosis suppresses the initiation and development of allergic airway inflammation. Mucosal Immunology. PMID 25783969 DOI: 10.1038/Mi.2015.16  0.368
2013 Mogie G, Shanks K, Nkyimbeng-Takwi EH, Smith E, Davila E, Lipsky MM, DeTolla LJ, Keegan AD, Chapoval SP. Neuroimmune semaphorin 4A as a drug and drug target for asthma. International Immunopharmacology. 17: 568-75. PMID 23994348 DOI: 10.1016/J.Intimp.2013.08.005  0.341
2013 Dasgupta P, Qi X, Smith EP, Keegan AD. Absence of the common gamma chain (γ(c)), a critical component of the Type I IL-4 receptor, increases the severity of allergic lung inflammation. Plos One. 8: e71344. PMID 23940740 DOI: 10.1371/Journal.Pone.0071344  0.675
2013 Shanks K, Nkyimbeng-Takwi EH, Smith E, Lipsky MM, DeTolla LJ, Scott DW, Keegan AD, Chapoval SP. Neuroimmune semaphorin 4D is necessary for optimal lung allergic inflammation. Molecular Immunology. 56: 480-7. PMID 23911404 DOI: 10.1016/J.Molimm.2013.05.228  0.543
2013 Dorsey NJ, Chapoval SP, Smith EP, Skupsky J, Scott DW, Keegan AD. STAT6 controls the number of regulatory T cells in vivo, thereby regulating allergic lung inflammation. Journal of Immunology (Baltimore, Md. : 1950). 191: 1517-28. PMID 23825312 DOI: 10.4049/Jimmunol.1300486  0.733
2013 Porter HA, Perry A, Kingsley C, Tran NL, Keegan AD. IRS1 is highly expressed in localized breast tumors and regulates the sensitivity of breast cancer cells to chemotherapy, while IRS2 is highly expressed in invasive breast tumors. Cancer Letters. 338: 239-48. PMID 23562473 DOI: 10.1016/J.Canlet.2013.03.030  0.753
2013 Rajaiah R, Perkins DJ, Polumuri SK, Zhao A, Keegan AD, Vogel SN. Dissociation of endotoxin tolerance and differentiation of alternatively activated macrophages. Journal of Immunology (Baltimore, Md. : 1950). 190: 4763-72. PMID 23543762 DOI: 10.4049/Jimmunol.1202407  0.455
2013 Yang Z, Grinchuk V, Urban JF, Bohl J, Sun R, Notari L, Yan S, Ramalingam T, Keegan AD, Wynn TA, Shea-Donohue T, Zhao A. Macrophages as IL-25/IL-33-responsive cells play an important role in the induction of type 2 immunity. Plos One. 8: e59441. PMID 23536877 DOI: 10.1371/Journal.Pone.0059441  0.514
2012 Heller NM, Qi X, Gesbert F, Keegan AD. The extracellular and transmembrane domains of the γC and interleukin (IL)-13 receptor α1 chains, not their cytoplasmic domains, dictate the nature of signaling responses to IL-4 and IL-13. The Journal of Biological Chemistry. 287: 31948-61. PMID 22829596 DOI: 10.1074/Jbc.M112.348896  0.511
2012 Luzina IG, Keegan AD, Heller NM, Rook GA, Shea-Donohue T, Atamas SP. Regulation of inflammation by interleukin-4: a review of "alternatives". Journal of Leukocyte Biology. 92: 753-64. PMID 22782966 DOI: 10.1189/Jlb.0412214  0.521
2012 Heller NM, Gwinn WM, Donnelly RP, Constant SL, Keegan AD. IL-4 engagement of the type I IL-4 receptor complex enhances mouse eosinophil migration to eotaxin-1 in vitro. Plos One. 7: e39673. PMID 22761864 DOI: 10.1371/Journal.Pone.0039673  0.522
2012 Porter HA, Carey GB, Keegan AD. Insulin receptor substrate 1 expression enhances the sensitivity of 32D cells to chemotherapy-induced cell death. Experimental Cell Research. 318: 1745-58. PMID 22652453 DOI: 10.1016/J.Yexcr.2012.04.020  0.759
2012 Nkyimbeng-Takwi EH, Shanks K, Smith E, Iyer A, Lipsky MM, Detolla LJ, Kikutani H, Keegan AD, Chapoval SP. Neuroimmune semaphorin 4A downregulates the severity of allergic response. Mucosal Immunology. 5: 409-19. PMID 22472774 DOI: 10.1038/Mi.2012.18  0.518
2012 Dasgupta P, Keegan AD. Contribution of alternatively activated macrophages to allergic lung inflammation: a tale of mice and men. Journal of Innate Immunity. 4: 478-88. PMID 22440980 DOI: 10.1159/000336025  0.581
2012 Ford AQ, Dasgupta P, Mikhailenko I, Smith EM, Noben-Trauth N, Keegan AD. Adoptive transfer of IL-4Rα+ macrophages is sufficient to enhance eosinophilic inflammation in a mouse model of allergic lung inflammation. Bmc Immunology. 13: 6. PMID 22292924 DOI: 10.1186/1471-2172-13-6  0.66
2012 Ganz T, Madera L, Hancock REW, Suzuki T, Yamamoto N, Watanabe M, Takaku H, Chang MO, Cortez-Retamozo V, Etzrodt M, Pittet MJ, Anders H, Weidenbusch M, Gordon S, Fisher EA, ... ... Keegan AD, et al. Contents Vol. 4, 2012 Journal of Innate Immunity. 4. DOI: 10.1159/000341372  0.416
2012 Dorsey N, Chapoval S, Smith E, Skupsky J, Scott D, Keegan A. 1. Control Of T-regulatory Cells By Stat6 During Allergic Lung Inflammation Journal of Allergy and Clinical Immunology. 129: AB197. DOI: 10.1016/J.Jaci.2011.12.301  0.698
2011 Dasgupta P, Chapoval SP, Smith EP, Keegan AD. Transfer of in vivo primed transgenic T cells supports allergic lung inflammation and FIZZ1 and Ym1 production in an IL-4Rα and STAT6 dependent manner. Bmc Immunology. 12: 60. PMID 22014099 DOI: 10.1186/1471-2172-12-60  0.691
2011 Prabhakara R, Harro JM, Leid JG, Keegan AD, Prior ML, Shirtliff ME. Suppression of the inflammatory immune response prevents the development of chronic biofilm infection due to methicillin-resistant Staphylococcus aureus. Infection and Immunity. 79: 5010-8. PMID 21947772 DOI: 10.1128/Iai.05571-11  0.35
2011 Yu M, Qi X, Moreno JL, Farber DL, Keegan AD. NF-κB signaling participates in both RANKL- and IL-4-induced macrophage fusion: receptor cross-talk leads to alterations in NF-κB pathways. Journal of Immunology (Baltimore, Md. : 1950). 187: 1797-806. PMID 21734075 DOI: 10.4049/Jimmunol.1002628  0.652
2011 Lai W, Yu M, Huang MN, Okoye F, Keegan AD, Farber DL. Transcriptional control of rapid recall by memory CD4 T cells. Journal of Immunology (Baltimore, Md. : 1950). 187: 133-40. PMID 21642544 DOI: 10.4049/Jimmunol.1002742  0.598
2011 Myneni SR, Settem RP, Connell TD, Keegan AD, Gaffen SL, Sharma A. TLR2 signaling and Th2 responses drive Tannerella forsythia-induced periodontal bone loss. Journal of Immunology (Baltimore, Md. : 1950). 187: 501-9. PMID 21632710 DOI: 10.4049/Jimmunol.1100683  0.399
2011 Smith EP, Shanks K, Lipsky MM, DeTolla LJ, Keegan AD, Chapoval SP. Expression of neuroimmune semaphorins 4A and 4D and their receptors in the lung is enhanced by allergen and vascular endothelial growth factor. Bmc Immunology. 12: 30. PMID 21595947 DOI: 10.1186/1471-2172-12-30  0.377
2011 Mathews JA, Ford J, Norton S, Kang D, Dellinger A, Gibb DR, Ford AQ, Massay H, Kepley CL, Scherle P, Keegan AD, Conrad DH. A potential new target for asthma therapy: a disintegrin and metalloprotease 10 (ADAM10) involvement in murine experimental asthma. Allergy. 66: 1193-200. PMID 21557750 DOI: 10.1111/J.1398-9995.2011.02614.X  0.385
2011 Luzina IG, Lockatell V, Todd NW, Highsmith K, Keegan AD, Hasday JD, Atamas SP. Alternatively spliced variants of interleukin-4 promote inflammation differentially. Journal of Leukocyte Biology. 89: 763-70. PMID 21285395 DOI: 10.1189/Jlb.0510271  0.507
2011 Chapoval SP, Dasgupta P, Smith EP, DeTolla LJ, Lipsky MM, Kelly-Welch AE, Keegan AD. STAT6 expression in multiple cell types mediates the cooperative development of allergic airway disease. Journal of Immunology (Baltimore, Md. : 1950). 186: 2571-83. PMID 21242523 DOI: 10.4049/Jimmunol.1002567  0.65
2011 Luzina IG, Lockatell V, Todd NW, Keegan AD, Hasday JD, Atamas SP. Splice isoforms of human interleukin-4 are functionally active in mice in vivo. Immunology. 132: 385-93. PMID 21219317 DOI: 10.1111/J.1365-2567.2010.03393.X  0.531
2010 Shirey KA, Pletneva LM, Puche AC, Keegan AD, Prince GA, Blanco JC, Vogel SN. Control of RSV-induced lung injury by alternatively activated macrophages is IL-4R alpha-, TLR4-, and IFN-beta-dependent. Mucosal Immunology. 3: 291-300. PMID 20404812 DOI: 10.1038/Mi.2010.6  0.396
2010 Chapoval S, Dasgupta P, Dorsey NJ, Keegan AD. Regulation of the T helper cell type 2 (Th2)/T regulatory cell (Treg) balance by IL-4 and STAT6. Journal of Leukocyte Biology. 87: 1011-8. PMID 20335310 DOI: 10.1189/Jlb.1209772  0.766
2010 Porter HA, Keegan AD. Abstract 4014: Differential expression and activation of IRS1 and IRS2 in breast cancer cell lines Cancer Research. 70: 4014-4014. DOI: 10.1158/1538-7445.Am10-4014  0.792
2009 Yu M, Moreno JL, Stains JP, Keegan AD. Complex regulation of tartrate-resistant acid phosphatase (TRAP) expression by interleukin 4 (IL-4): IL-4 indirectly suppresses receptor activator of NF-kappaB ligand (RANKL)-mediated TRAP expression but modestly induces its expression directly. The Journal of Biological Chemistry. 284: 32968-79. PMID 19801646 DOI: 10.1074/Jbc.M109.001016  0.679
2009 Ford AQ, Heller NM, Stephenson L, Boothby MR, Keegan AD. An atopy-associated polymorphism in the ectodomain of the IL-4R(alpha) chain (V50) regulates the persistence of STAT6 phosphorylation. Journal of Immunology (Baltimore, Md. : 1950). 183: 1607-16. PMID 19592641 DOI: 10.4049/jimmunol.0803266  0.36
2009 Chapoval SP, Lee CG, Tang C, Keegan AD, Cohn L, Bottomly K, Elias JA. Lung vascular endothelial growth factor expression induces local myeloid dendritic cell activation. Clinical Immunology (Orlando, Fla.). 132: 371-84. PMID 19553159 DOI: 10.1016/J.Clim.2009.05.016  0.315
2008 Heller NM, Qi X, Junttila IS, Shirey KA, Vogel SN, Paul WE, Keegan AD. Type I IL-4Rs selectively activate IRS-2 to induce target gene expression in macrophages. Science Signaling. 1: ra17. PMID 19109239 DOI: 10.1126/Scisignal.1164795  0.52
2008 Shirey KA, Cole LE, Keegan AD, Vogel SN. Francisella tularensis live vaccine strain induces macrophage alternative activation as a survival mechanism. Journal of Immunology (Baltimore, Md. : 1950). 181: 4159-67. PMID 18768873 DOI: 10.4049/Jimmunol.181.6.4159  0.459
2008 LaPorte SL, Juo ZS, Vaclavikova J, Colf LA, Qi X, Heller NM, Keegan AD, Garcia KC. Molecular and structural basis of cytokine receptor pleiotropy in the interleukin-4/13 system. Cell. 132: 259-72. PMID 18243101 DOI: 10.1016/j.cell.2007.12.030  0.361
2008 HELLER N, QI X, JUNTTILA I, PAUL W, KEEGAN A. The Type I Il-4 Receptor Complex Selectively Activates The Tyrosine Phosphorylation Of IRS-2 Journal of Allergy and Clinical Immunology. 121: S48-S48. DOI: 10.1016/J.Jaci.2007.12.196  0.411
2008 Chapoval SP, Kelly-Welch AE, Smith E, Keegan AD. 29 Antagonistic role of STAT6 for regulatory T-cells Cytokine. 43: 243. DOI: 10.1016/J.Cyto.2008.07.070  0.403
2008 Porter HA, Keegan AD. 16 IRS1 expression enhances the sensitivity of 32D cells to chemotherapy-induced cell death Cytokine. 43: 240. DOI: 10.1016/J.Cyto.2008.07.056  0.749
2007 Carey GB, Semenova E, Qi X, Keegan AD. IL-4 protects the B-cell lymphoma cell line CH31 from anti-IgM-induced growth arrest and apoptosis: contribution of the PI-3 kinase/AKT pathway. Cell Research. 17: 942-55. PMID 17968425 DOI: 10.1038/Sj.Cr.2007.90  0.514
2007 Moreno JL, Mikhailenko I, Tondravi MM, Keegan AD. IL-4 promotes the formation of multinucleated giant cells from macrophage precursors by a STAT6-dependent, homotypic mechanism: contribution of E-cadherin. Journal of Leukocyte Biology. 82: 1542-53. PMID 17855502 DOI: 10.1189/Jlb.0107058  0.536
2006 Gwinn WM, Damsker JM, Falahati R, Okwumabua I, Kelly-Welch A, Keegan AD, Vanpouille C, Lee JJ, Dent LA, Leitenberg D, Bukrinsky MI, Constant SL. Novel approach to inhibit asthma-mediated lung inflammation using anti-CD147 intervention. Journal of Immunology (Baltimore, Md. : 1950). 177: 4870-9. PMID 16982929 DOI: 10.4049/Jimmunol.177.7.4870  0.34
2005 Yamada A, Sheikh F, Niimi T, DeMayo FJ, Keegan AD, Donnelly RP, Kimura S. Induction of uteroglobin-related protein 2 (Ugrp2) gene expression by the Th2 cytokines IL-4 and IL-13. Journal of Immunology (Baltimore, Md. : 1950). 175: 5708-15. PMID 16237061 DOI: 10.4049/Jimmunol.175.9.5708  0.524
2005 Greeneltch KM, Kelly-Welch AE, Shi Y, Keegan AD. Chronic morphine treatment promotes specific Th2 cytokine production by murine T cells in vitro via a Fas/Fas ligand-dependent mechanism. Journal of Immunology (Baltimore, Md. : 1950). 175: 4999-5005. PMID 16210602 DOI: 10.4049/Jimmunol.175.8.4999  0.523
2005 Kelly-Welch A, Hanson EM, Keegan AD. Interleukin-4 (IL-4) pathway. Science's Stke : Signal Transduction Knowledge Environment. 2005: cm9. PMID 16030287 DOI: 10.1126/Stke.2932005Cm9  0.518
2005 Kelly-Welch A, Hanson EM, Keegan AD. Interleukin-13 (IL-13) pathway. Science's Stke : Signal Transduction Knowledge Environment. 2005: cm8. PMID 16030286 DOI: 10.1126/Stke.2932005Cm8  0.524
2005 Yu WM, Wang S, Keegan AD, Williams MS, Qu CK. Abnormal Th1 cell differentiation and IFN-gamma production in T lymphocytes from motheaten viable mice mutant for Src homology 2 domain-containing protein tyrosine phosphatase-1. Journal of Immunology (Baltimore, Md. : 1950). 174: 1013-9. PMID 15634925 DOI: 10.4049/Jimmunol.174.2.1013  0.554
2004 Bunting KD, Yu WM, Bradley HL, Haviernikova E, Kelly-Welch AE, Keegan AD, Qu CK. Increased numbers of committed myeloid progenitors but not primitive hematopoietic stem/progenitors in mice lacking STAT6 expression. Journal of Leukocyte Biology. 76: 484-90. PMID 15123777 DOI: 10.1189/Jlb.0903440  0.512
2004 Kelly-Welch AE, Melo ME, Smith E, Ford AQ, Haudenschild C, Noben-Trauth N, Keegan AD. Complex role of the IL-4 receptor alpha in a murine model of airway inflammation: expression of the IL-4 receptor alpha on nonlymphoid cells of bone marrow origin contributes to severity of inflammation. Journal of Immunology (Baltimore, Md. : 1950). 172: 4545-55. PMID 15034072 DOI: 10.4049/Jimmunol.172.7.4545  0.543
2004 Kelly-Welch AE, Wang HY, Wang LM, Pierce JH, Jay G, Finkelman F, Keegan AD. Transgenic expression of insulin receptor substrate 2 in murine B cells alters the cell density-dependence of IgE production in vitro and enhances IgE production in vivo. Journal of Immunology (Baltimore, Md. : 1950). 172: 2803-10. PMID 14978080 DOI: 10.4049/Jimmunol.172.5.2803  0.496
2004 Zhang XR, Zhang LY, Devadas S, Li L, Keegan AD, Shi YF. Reciprocal expression of TRAIL and CD95L in Th1 and Th2 cells: role of apoptosis in T helper subset differentiation. Cell Death and Differentiation. 10: 203-10. PMID 12700648 DOI: 10.1038/Sj.Cdd.4401138  0.457
2003 Roberts AI, Devadas S, Zhang X, Zhang L, Keegan A, Greeneltch K, Solomon J, Wei L, Das J, Sun E, Liu C, Yuan Z, Zhou JN, Shi Y. The Role of Activation-Induced Cell Death in the Differentiation of T-Helper-Cell Subsets Immunologic Research. 28: 285-293. PMID 14713720 DOI: 10.1385/Ir:28:3:285  0.367
2003 Zamorano J, Rivas MD, Garcia-Trinidad A, Qu CK, Keegan AD. Phosphatidylcholine-specific phospholipase C activity is necessary for the activation of STAT6. Journal of Immunology (Baltimore, Md. : 1950). 171: 4203-9. PMID 14530343 DOI: 10.4049/Jimmunol.171.8.4203  0.466
2003 Mora AL, Stephenson LM, Enerson B, Youn J, Keegan AD, Boothby M. New programming of IL-4 receptor signal transduction in activated T cells: Stat6 induction and Th2 differentiation mediated by IL-4Ralpha lacking cytoplasmic tyrosines. Journal of Immunology (Baltimore, Md. : 1950). 171: 1891-900. PMID 12902491 DOI: 10.4049/Jimmunol.171.4.1891  0.548
2003 Kelly-Welch AE, Hanson EM, Boothby MR, Keegan AD. Interleukin-4 and interleukin-13 signaling connections maps. Science (New York, N.Y.). 300: 1527-8. PMID 12791978 DOI: 10.1126/science.1085458  0.422
2003 Moreno JL, Kaczmarek M, Keegan AD, Tondravi M. IL-4 suppresses osteoclast development and mature osteoclast function by a STAT6-dependent mechanism: irreversible inhibition of the differentiation program activated by RANKL. Blood. 102: 1078-86. PMID 12689929 DOI: 10.1182/Blood-2002-11-3437  0.52
2003 Hanson EM, Dickensheets H, Qu CK, Donnelly RP, Keegan AD. Regulation of the dephosphorylation of Stat6. Participation of Tyr-713 in the interleukin-4 receptor alpha, the tyrosine phosphatase SHP-1, and the proteasome. The Journal of Biological Chemistry. 278: 3903-11. PMID 12459556 DOI: 10.1074/Jbc.M211747200  0.48
2002 Li L, Qi X, Williams M, Shi Y, Keegan AD. Overexpression of insulin receptor substrate-1, but not insulin receptor substrate-2, protects a T cell hybridoma from activation-induced cell death. Journal of Immunology (Baltimore, Md. : 1950). 168: 6215-23. PMID 12055235 DOI: 10.4049/Jimmunol.168.12.6215  0.44
2002 Perez-G M, Melo M, Keegan AD, Zamorano J. Aspirin and salicylates inhibit the IL-4- and IL-13-induced activation of STAT6. Journal of Immunology (Baltimore, Md. : 1950). 168: 1428-34. PMID 11801685 DOI: 10.4049/Jimmunol.168.3.1428  0.512
2002 Zamorano J, Mora AL, Boothby M, Keegan AD. NF-kappa B activation plays an important role in the IL-4-induced protection from apoptosis. International Immunology. 13: 1479-87. PMID 11717189 DOI: 10.1093/Intimm/13.12.1479  0.522
2001 Zamorano J, Kelly AE, Austrian J, Wang HY, Keegan AD. Costimulation of resting B lymphocytes alters the IL-4-activated IRS2 signaling pathway in a STAT6 independent manner: implications for cell survival and proliferation. Cell Research. 11: 44-54. PMID 11305324 DOI: 10.1038/Sj.Cr.7290065  0.534
2001 Mora A, Youn J, Keegan A, Boothby M. NF-kappa B/Rel participation in the lymphokine-dependent proliferation of T lymphoid cells. Journal of Immunology (Baltimore, Md. : 1950). 166: 2218-27. PMID 11160275 DOI: 10.4049/Jimmunol.166.4.2218  0.554
1999 Nelms K, Keegan AD, Zamorano J, Ryan JJ, Paul WE. The IL-4 receptor: signaling mechanisms and biologic functions. Annual Review of Immunology. 17: 701-38. PMID 10358772 DOI: 10.1146/Annurev.Immunol.17.1.701  0.444
1998 Nelms K, Huang H, Ryan J, Keegan A, Paul WE. Interleukin-4 receptor signalling mechanisms and their biological significance. Advances in Experimental Medicine and Biology. 452: 37-43. PMID 9889957 DOI: 10.1007/978-1-4615-5355-7_5  0.459
1998 Keegan AD, Zamorano J. Regulation of gene expression, growth, and cell survival by IL-4: contribution of multiple signaling pathways. Cell Research. 8: 1-13. PMID 9570012 DOI: 10.1038/Cr.1998.1  0.544
1998 Wang HY, Zamorano J, Keegan AD. A role for the insulin-interleukin (IL)-4 receptor motif of the IL-4 receptor alpha-chain in regulating activation of the insulin receptor substrate 2 and signal transducer and activator of transcription 6 pathways. Analysis by mutagenesis. The Journal of Biological Chemistry. 273: 9898-905. PMID 9545332 DOI: 10.1074/Jbc.273.16.9898  0.467
1997 Wang D, Zamorano J, Keegan AD, Boothby M. HMG-I(Y) phosphorylation status as a nuclear target regulated through insulin receptor substrate-1 and the I4R motif of the interleukin-4 receptor. The Journal of Biological Chemistry. 272: 25083-90. PMID 9312117 DOI: 10.1074/jbc.272.40.25083  0.413
1996 Ryan JJ, McReynolds LJ, Keegan A, Wang LH, Garfein E, Rothman P, Nelms K, Paul WE. Growth and gene expression are predominantly controlled by distinct regions of the human IL-4 receptor Immunity. 4: 123-132. PMID 8624803 DOI: 10.1016/S1074-7613(00)80677-9  0.466
1996 Wang HY, Paul WE, Keegan AD. IL-4 function can be transferred to the IL-2 receptor by tyrosine containing sequences found in the IL-4 receptor alpha chain. Immunity. 4: 113-21. PMID 8624802 DOI: 10.1016/S1074-7613(00)80676-7  0.473
1995 Keegan A, Nelms K, Paul WE. The IL-4 receptor--signaling mechanisms. Advances in Experimental Medicine and Biology. 365: 211-5. PMID 7887305 DOI: 10.1007/978-1-4899-0987-9_21  0.472
1995 Quelle FW, Shimoda K, Thierfelder W, Fischer C, Kim A, Ruben SM, Cleveland JL, Pierce JH, Keegan AD, Nelms K. Cloning of murine Stat6 and human Stat6, Stat proteins that are tyrosine phosphorylated in responses to IL-4 and IL-3 but are not required for mitogenesis. Molecular and Cellular Biology. 15: 3336-43. PMID 7760829 DOI: 10.1128/Mcb.15.6.3336  0.39
1995 Kinzer CA, Keegan AD, Paul WE. Identification of Fc epsilon RIneg mast cells in mouse bone marrow cell cultures. Use of a monoclonal anti-p161 antibody. The Journal of Experimental Medicine. 182: 575-9. PMID 7629514 DOI: 10.1084/jem.182.2.575  0.366
1995 Pernis A, Witthuhn B, Keegan AD, Nelms K, Garfein E, Ihle JN, Paul WE, Pierce JH, Rothman P. Interleukin 4 signals through two related pathways. Proceedings of the National Academy of Sciences of the United States of America. 92: 7971-5. PMID 7544011 DOI: 10.1073/Pnas.92.17.7971  0.419
1995 Keegan AD, Johnston JA, Tortolani PJ, Mcreynolds LJ, Kinzer C, O'Shea JJ, Paul WE. Similarities and differences in signal transduction by interleukin 4 and interleukin 13: Analysis of Janus kinase activation Proceedings of the National Academy of Sciences of the United States of America. 92: 7681-7685. PMID 7544000 DOI: 10.1073/Pnas.92.17.7681  0.402
1994 Keegan AD, Nelms K, White M, Wang LM, Pierce JH, Paul WE. An IL-4 receptor region containing an insulin receptor motif is important for IL-4-mediated IRS-1 phosphorylation and cell growth. Cell. 76: 811-20. PMID 8124718 DOI: 10.1016/0092-8674(94)90356-5  0.399
1994 Keegan AD, Nelms K, Wang LM, Pierce JH, Paul WE. Interleukin 4 receptor: signaling mechanisms. Immunology Today. 15: 423-32. PMID 7945783 DOI: 10.1016/0167-5699(94)90272-0  0.392
1993 Russell SM, Keegan AD, Harada N, Nakamura Y, Noguchi M, Leland P, Friedmann MC, Miyajima A, Puri RK, Paul WE. Interleukin-2 receptor gamma chain: a functional component of the interleukin-4 receptor. Science (New York, N.Y.). 262: 1880-3. PMID 8266078 DOI: 10.1126/science.8266078  0.35
1992 Wang L, Keegan A, Paul W, Heidaran M, Gutkind J, Pierce J. IL-4 activates a distinct signal transduction cascade from IL-3 in factor-dependent myeloid cells. The Embo Journal. 11: 4899-4908. DOI: 10.1002/j.1460-2075.1992.tb05596.x  0.412
Show low-probability matches.